Shaperon is Drug Discovery in South Korea that focus on low immunogenicity business. Founded in 2008. They cover business area such as developer, nanobody-base cancer therapeutic, high affinity, low immunogenicity, damp, (damage-associate molecular pattern, multi-modal, complex inflammatory disease, immune-modulate molecule, strong efficacy, excellent safety profile, physician.
2008
( 16 years old in 2024 )
Low Immunogenicity
-
Gangnam Ace Tower G9, 174-10 Jagok-ro
Suite 606
Seoul, Gangnam-gu
South Korea
Private
developernanobody-base cancer therapeutichigh affinitylow immunogenicitydamp(damage-associate molecular patternmulti-modal, complex inflammatory diseaseimmune-modulate moleculestrong efficacyexcellent safety profilephysician
* We use standard office opening hours in near Shaperon's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Shaperon is Drug Discovery business from South Korea that founded in 2008 (16 years old in 2024), Shaperon business is focusing on Low Immunogenicity.
Shaperon headquarter office and corporate office address is located in Gangnam Ace Tower G9, 174-10 Jagok-ro Suite 606 Seoul, Gangnam-gu South Korea.
Shaperon was founded in South Korea.
In 2024, Shaperon is currently focus on low immunogenicity sector.
Above is snippet of Google Trends for "low immunogenicity" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Shaperon, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
